NCIMB and GitLife win innovate UK funding to support development of new therapeutic solutions

Aberdeen-based biotechnology company NCIMB is teaming up with innovative Newcastle University Spinout GitLife Biotech in a 12-month project that will investigate the therapeutic potential of gut microbes. The project aims to develop a new class of therapeutics based on living bacteria to prevent or treat disease.  The work has been funded by Innovate UK, part of UK Research and Innovation (UKRI) The project will use engineering biology to enhance the therapeutic potential of microbial strains from NCIMB’s culture collection. Explaining more about the work, NCIMB’s CEO Dr Edward Green said: …